Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.

Kent, Collin L; McDuff, Susan G R; Salama, Joseph K

Kent, Collin L; McDuff, Susan G R; Salama, Joseph K.

Afiliación

Kent CL; Department of Radiation Oncology, Duke University, Durham, NC, USA.
McDuff SGR; Department of Radiation Oncology, Duke University, Durham, NC, USA.
Salama JK; Department of Radiation Oncology, Duke University, Durham, NC, USA; Radiation Oncology Service, Durham VA Medical Center, Durham, NC, USA.

Ann Palliat Med ; 10(5): 5954-5968, 2021 May.

Article en En | MEDLINE | ID: mdl-32921069

Asunto(s)

Neoplasias de la Mama; Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Radiocirugia; Neoplasias de la Mama/terapia; Humanos; Neoplasias Pulmonares/terapia; Masculino; Estudios Prospectivos; Estudios Retrospectivos

Palabras clave

Radiofrequency ablation (RFA); hypofractionated image-guided radiation therapy (HIGRT); liver resection; oligometastases; stereotactic ablative radiotherapy (SABR); stereotactic body radiation therapy (SBRT); trans-arterial chemotherapy (TACE)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Radiocirugia / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies Idioma: En Revista: Ann Palliat Med Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google